Listen Up

Tuesday, August 27, 2024

Is your Medical Record safe from LLMs and ChatGPT

The answer is Yes.

Can LLMs or AI (ChatGPT) access the Electronic Medical Record?

Large language models (LLMs) ensure patient privacy in several ways:

No Direct Access: LLMs do not have access to electronic health records or personal data. They operate based on pre-existing knowledge and patterns learned during training.


Data Anonymization: Training data is typically anonymized, meaning personal identifiers are removed. This reduces the risk of generating responses that could inadvertently reveal private information.
Strict Compliance

Developers of LLMs adhere to privacy regulations, such as HIPAA, which govern the handling of sensitive health information.
Controlled Environments: 

When LLMs are used in healthcare settings, they are often implemented in controlled environments with strict access controls and monitoring.
User Prompts: LLMs are designed to avoid engaging with prompts that request sensitive personal information or that might compromise privacy.
Ethical Guidelines: Organizations deploying LLMs often follow ethical guidelines that prioritize user privacy and data protection.

In addition to the limitations for LLMs

The electronic health record (EHR) system is designed to protect patient information in several ways:

Access Controls:

EHRs have robust user authentication and authorization mechanisms, such as secure login credentials, multi-factor authentication, and role-based access controls.

Healthcare providers and staff can only access the specific patient information they need to perform their job duties.

Data Encryption:

Patient data stored in the EHR is encrypted using advanced encryption algorithms to protect it from unauthorized access.

Data transmitted between the EHR and other healthcare systems or patient portals is also encrypted to ensure confidentiality.

Audit Trails:

EHRs maintain detailed audit logs that record all access, modifications, and actions performed on patient data.

These audit trails help healthcare organizations monitor and investigate any suspicious or unauthorized activities.

Data Backups and Disaster Recovery:

EHR systems implement regular data backups and have robust disaster recovery plans to ensure the availability and integrity of patient information in case of system failures or natural disasters.

Compliance with Regulations:

EHR systems are designed to comply with various healthcare privacy and security regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States.

These regulations set strict standards for the protection of patient information and impose penalties for non-compliance.

Physical Security:

EHR systems are hosted in secure data centers with physical access controls, such as biometric scanners and security cameras, to prevent unauthorized physical access to the systems.

Patient Engagement and Control:

Many EHR systems offer patient portals, allowing patients to access and review their own medical records, as well as request corrections or express concerns about the privacy of their information.

By implementing these security measures, EHR systems aim to protect the confidentiality, integrity, and availability of patient information, ensuring that healthcare providers can securely access and manage patient data while maintaining the trust and privacy of patients.

Tuesday, August 20, 2024

Health News Notes

US Birth Rate Hits New Low




Mpox outbreak concerns grow


More Than Half of IRA Negotiation Savings to Come From Three Drugs:


Continuing our discussion about Medicare Drug Price Negotiations.

Amgen’s Enbrel, Bristol Myers Squibb’s Eliquis and Johnson & Johnson’s Stelara will account for 51.4% of the Inflation Reduction Act’s drug price negotiation savings in 2026, according to the Brookings Institution.


A little known feature of the IRA gave CMS the ability to negotiate drug prices.

These savings indicate how much of the federal government's budget goes to Medicare's drug benefit for seniors.

The drugs were designed to treat some of the most frequent illnesses in the population, arthritis, blood clots in heart disease, and psoriasis.




More Than Half of IRA Negotiation Savings to Come From Three Drugs: Report - BioSpace

Monday, August 19, 2024

Medicare has negotiated price cuts for 10 Drugs


CMS (Medicare) controls a large part of the pharmaceuticals used by patients and they have considerable influence on pharma.

Medicare beneficiaries will benefit by price reductions for drugs intended for patients with common diseases, such as diabetes, heart failure, psoriasis, ulcerative colitis, blood clotting disorders, and blood cancers

The discounts are considerable ranging from 79%% to 36%

Here’s the list:

Januvia: Manufactured by Merck Sharp Dohme to treat diabetes, the negotiated price is $113 for a 30-day supply, which is a 79% reduction 

 Fiasp  (insulin} FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill: Manufactured by Novo Nordisk to treat diabetes, the negotiated price is $119 for a 30- day supply, which is a 76% reduction. 

Farxiga: Manufactured by AstraZeneca AB to treat diabetes, heart failure and chronic kidney disease, the negotiated price is $178.50 for a 30-day supply, a reduction of 68%. 

Enbrel: Manufactured by Immunex Corp. to treat rheumatoid arthritis, psoriasis and psoriatic arthritis, the negotiated price is $2,355 for a 30-day supply, which is a 67% cut. 

Jardiance: Manufactured by Boehringer Ingelheim to treat diabetes, heart failure and chronic kidney disease, the negotiated price is $197 for a 30-day supply, which is a 66% savings. 

Stelara: Manufactured by Janssen Biotech Inc. to treat Psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis, the negotiated price is $4,695 for a 30-day supply, which is a 66% reduction. 

Xarelto: Manufactured by Janssen Pharms for prevention and treatment of blood clots, and reduction of risk for patients with coronary or peripheral artery disease, the negotiated price is $197 for a 30-day supply. It’s a 62% reduction 

Eliquis: Manufactured by Bristol Myers Squibb for prevention and treatment of blood clots, the negotiated price is $231 for a 30-day supply, reduction of 56% 

Entresto: Manufactured by Novartis Pharms Corp to treat heart failure, the negotiated price is $295 for a 30-day supply, which is a 53% reduction. 

Imbruvica: Manufactured by Pharmacyclics LLC to treat blood cancers, the negotiated price is $9,319 for a 30-day supply, which is a 38% cut. 

These drugs are heavily marketed by the media on television and cable television.

Patient awareness causes them to ask for these drugs from physicians. The fact that there have been significant reductions in prices will increase patient demand.

Whatever price reductions the increase in demand will offset the reduction in price.

Thursday, August 15, 2024

Private Equity Ownership of Medical Practice and Hospital Ownership and What it does to the Health Care System

Why private equity is bad for your health.


Key Points

  • During the first half of 2024, nine private equity-owned healthcare companies have filed for bankruptcy, comprising 23% of all large US healthcare bankruptcies so far this year.
  • Some other private equity-owned healthcare companies have also defaulted on their debt but avoided bankruptcy court through distressed debt exchanges. At least six major healthcare companies have completed distressed exchanges this year.
  • Many more private equity-owned healthcare companies are highly leveraged and considered at high risk for bankruptcy, including multiple companies that have taken on debt to finance payouts to their private equity owners.

Private equity firms, which characteristically use excessive debt and aggressive financial strategies, are key drivers in a recent wave of healthcare bankruptcies in the US, threatening the stability of essential healthcare services across the country.

In our April report, PESP found that at least 17 (21%) of the 80 large healthcare companies that filed for bankruptcy last year were owned by private equity firms.

This trend has continue in 2024. In the first six months of this year, PESP has tracked at least nine bankruptcies by companies that were private equity-owned, which accounts for 23% of all healthcare bankruptcies filed this year.

On top of that, there have been at least six more defaults by PE-owned healthcare companies (where the companies managed to restructure their debt outside of bankruptcy court).

The rise in healthcare bankruptcies, and bankruptcies by private equity-owned healthcare companies in particular, stems from a few factors. Private equity firms routinely use much higher levels of debt than other companies, often the result of leveraged buyouts and aggressive debt-funded growth strategies.

Private equity owns or recently owned companies that accounted for three of the four largest healthcare bankruptcies of the year so far, where the companies’ total liabilities exceeded $1 billion: Consulate Health Care, Steward Health Care, and Cano Health.[13]

Not included in that list is Careismatic Brands, a medical scrubs manufacturer owned by Partners Group that also had a >$1 billion bankruptcy,[14] but is classified within the consumer discretionary market rather than healthcare.[15]

Some private equity firms even add additional debt to their portfolio companies to fund shareholder payouts, known as “dividend recapitalizations.” Just last month, private equity-owned medical debt collector Ensemble RCM took out an over $800 million loan to finance a payout to its private equity owners.[1]

Private equity’s aggressive use of debt leaves companies more vulnerable to changing market conditions, including high interest rates and rising labor costs.

Private Equity Bankruptcy Trend Has Continued in 2024

Of the 40 large healthcare companies that have filed for bankruptcy so far this year (January-June 2024), nine companies are or were recently backed by private equity, accounting for 23% of the total filings.[2]

Most of the bankruptcies are filed as Chapter 11, which allows for a financial reorganization over time to allow the PE to survive.  However many PEs in Chapter 11 proceed to Chapter 7 (a complete liquidation of all assets) In any case the entity is in the hands of a trustee who will make decisions on the PE's ability to meet the Chapter 11 bankruptcy or proceed to a Chapter 7 liquidation

To make matters worse PEs often borrow to pay shareholder dividends, to eliminate shareholder exits.

Any entity considering relief from a private entity should evaluate the buyer, its track record, financial statements, and history of previous acquisitions.

The makeup of PEs varies, from larger Venture Capital investors to smaller non-financial firms.  Firms may include individual hospitals, clinics, or smaller groups of interested competitors.. This group may include competitors who want to increase their market share to improve their value to insurers by expanding their coverage area.

Physician Involvement

Neophyte physicians should examine the financial health of their proposed employer.  They must avoid distressed entities such as group practices clinics and hospitals. Should the entity file for Chapter 7 many physicians could face loss of income and a forced move. Non-partners face the risk of termination, while partners may face liabilities for Chapter 7.  This is good. reason for having a personal Chapter S to shield themselves from personal liability.


Private equity healthcare bankruptcies show no signs of slowing

Tuesday, August 13, 2024

Which strains of tuberculosis are the most in | EurekAlert!


At a glance:

  • Highly localized TB strains are less infectious in cosmopolitan cities and more likely to infect people from the geographic area that is the strain’s natural habitat.

  • The findings offer new clues for tailoring preventive treatments after exposure to TB based on strain-host affinity.

  • The research provides the first controlled evidence that TB strains may evolve with their human hosts, adapting to be more infectious to specific populations.


For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a new study comparing how different strains move through mixed populations in cosmopolitan cities.

Results of the research, led by Harvard Medical School scientists and published Aug. 1 in Nature Microbiologyprovide the first hard evidence of long-standing observations that have led scientists to suspect that pathogen, place, and human host collide in a distinctive interplay that influences infection risk and fuels differences in susceptibility to infection.

The findings may also help inform new prevention and treatment approaches for tuberculosis, a wily pathogen that, each year, sickens more than 10 million people and causes more than a million deaths worldwide, according to the World Health Organization.

Where widespread Haarlem strains are prevalent

In these nations, at least 10 percent of the strains in a multinational database of tuberculosis genotypes were from the globally distributed Haarlem sublineage of Lineage 4, a group of TB varieties known as the Euro-American lineage that is prevalent around the world.

The widespread Haarlem sublineage of tuberculosis is prevalent in nations around the world, including countries in the Americas, Africa, Asia, and Europe.


 In the current analysis, believed to be the first controlled comparison of TB strains’ infectivity in populations of mixed geographic origins, the researchers custom-built a study cohort by combining case files from patients with TB in New York City, Amsterdam, and Hamburg. Doing so gave them enough data to power their models.

The analysis showed that close household contacts of people diagnosed with a strain of TB from a geographically restricted lineage had a 14 percent lower rate of infection and a 45 percent lower rate of developing active TB disease compared with those exposed to a strain belonging to a widespread lineage.

The study also showed that strains with narrow geographic ranges are much more likely to infect people with roots in the bacteria’s native geographic region than people from outside the region.

The researchers found that the odds of infection dropped by 38 percent when a contact is exposed to a restricted pathogen from a geographic region that doesn’t match the person’s background, compared with when a person is exposed to a geographically restricted microbe from a region that does match their home country. This was true for people who had lived in the region themselves and for people whose two parents could each trace their heritage to the region.

This pathogen-host affinity points to a shared evolution between humans and microbes with certain biological features rendering both more compatible and fueling the risk for infection, the researchers said.

“The size of the effect is surprisingly large,” said Maha Farhat, the Gilbert S. Omenn, MD ’65, PhD Associate Professor of Biomedical Informatics in the Blavatnik Institute at HMS. “That’s a good indicator that the impact on public health is substantial.”

Why differences matter

Thanks to the growing use of genetic sequencing, researchers have observed not all circulating strains are created equal. Some lineages are widespread and responsible for much of the TB around the world, while others are prevalent only in a few restricted areas. Given that the complex nature of TB transmission in high-incidence settings where people often have multiple exposures to different lineages, researchers have not been able to compare strains under similar conditions and have been left to speculate about possible explanations for the differences between strains.

Many factors increase the risk of contracting tuberculosis from a close contact. One of the best predictors of whether a person will infect their close contacts is bacterial load, measured by a test called sputum smear microscopy, which shows how many bacteria a person carries in their respiratory system.

However the new study showed that for geographically restricted strains, whether a person has ancestors who lived where the strain is common was an even bigger predictor of infection risk than bacterial load in the sputum. In the cases analyzed in the study, this risk of common ancestry even outweighed the risk stemming from having diabetes and other chronic diseases previously shown to render people more susceptible to infection.

The findings add to a growing body of evidence of the importance of paying attention to the wide variation between different lineages of tuberculosis and to the details of how different lineages of tuberculosis interact with different host populations.

Previous studies have shown that some genetic groups of TB are more prone to developing drug resistance and that TB vaccines appear to work better in some places than others. There is also evidence that some treatment regimens might be better suited to some strains of TB than others.

“These findings emphasize how important it is to understand what makes different strains of TB behave so differently from one another, and why some strains have such a close affinity for specific, related groups of people,” said Matthias Groeschel, research fellow in biomedical informatics in Farhat’s lab at HMS; resident physician at Charité, a university hospital in Berlin; and the study’s first author.

In addition to the analysis of clinical, genomic, and public health data, the researchers also tested the ability of different strains of TB to infect human macrophages, a type of immune cell that TB hijacks to cause infection and disease. The researchers grew cells from donors from different regions. Once again, cell lines from people with ancestry that matched the native habitat of a restricted strain of tuberculosis bacteria were more susceptible to the germs than cells from people from outside the area, mirroring the results of their epidemiologic study.

Until now, most experiments of the interaction between human immune cells and TB have not compared how TB interacts with cells of hosts from different populations or places, the researchers said.

While this experiment was not designed to capture insights about the mechanism underlying the affinity between human and TB populations sharing geographic backgrounds, it highlights the importance of using multiple strains of TB and cells from diverse populations to inform treatment and prevention. It also points to the need for more basic research to understand the genomic and structural differences in how bacterial and host cells interface, the researchers said.



Which strains of tuberculosis are the most in | EurekAlert!

Monday, August 12, 2024

Health Care is in a death spiral

 Death Spiral

1. Doctor Shortage, early retirement, or change to a nonclinical career. Boomer bulge. Incoming new doctors often get MBAs and go to non-clinical careers in IT,  or AI.

2. Nurse shortage.  Early dropout.

3. Hospital bed shortage

4. Continuing inflation at 8% / year

Monday, August 5, 2024

The Early Preveniton of Alzheimer's Diseae

As the population ages and physical health allows activities later in life, it becomes more important to recognize the early onset of dementia and/or Alzheimer's Disease

The future below outlines some early signs and symptoms of Alzheimer's Disease.

1. New research suggests that Alzheimer's disease may be reversible through lifestyle changes, including:

   - Adopting a plant-based diet

   - Engaging in regular exercise, including strength training

   - Practicing meditation or yoga

   - Increasing social engagement

2. The research study followed 51 adults in their 70s with mild cognitive impairment or early Alzheimer's. The group that made the lifestyle changes showed significant improvements, with 70% either stabilizing or markedly improving their cognitive function.

3. Examples of improvements seen in the study participants include:

   - Resumed ability to read, play music, manage affairs, and follow complex movie plots

   - Reversal of symptoms in a participant named Cici Zerbe, who made lifestyle changes after the study ended

4. Experts like Dr. Dean Ornish and Dr. Richard Isaacson recommend the following for brain health and Alzheimer's prevention:

   - Eating a mostly plant-based diet

   - Exercising regularly, including brisk walking with a weighted belt

   - Managing blood sugar levels

   - Maintaining mental stimulation and social engagement

5. The article highlights the personal experiences of Dr. Ornish and Dr. Gupta, who have had family members affected by Alzheimer's, and their motivation to explore lifestyle-based approaches to prevention and treatment.

In summary, the research suggests that Alzheimer's disease may be reversible through a combination of dietary, exercise, and lifestyle changes, providing hope for those affected by the disease.

'If Walmart can't do it … how can the average physician survive?': Independent practices becoming less feasible

Do you wonder why it takes so long to see a physician?  Besides to being required an enormous volume of patients, and being limited to ten-minute visits among the paucity of general physicians, there are an overwhelming number of financial constraints.


Independent physician practices are getting hit the hardest – only 44% of physicians owned their practice as of 2022, according to an American Medical Association report, compared with 76% in the early 1980s.

New data from consulting firm Avalere in a study sponsored by the Physicians Advocacy Institute estimated roughly 8,100 private practices were acquired by hospitals or corporations in 2022 and 2023, and 19,100 physicians became employees of hospitals or other corporate entities, up 5.1% since 2022. 

Physicians aren't the only ones struggling to meet margins in healthcare. Walmart announced plans to shutter all 51 health center locations and discontinue its virtual-care services in April. According to The Wall Street Journal, the company was unable to establish a sustainable business model despite positive patient feedback. 

CVS Health, who recently spent $11.5 billion acquiring Oak Street Health, is also facing headwinds. CVS was aiming to emulate the success of UnitedHealth Group, which owns Optum, the country's largest employer of physicians. But, according to the Journal, earnings have disappointed investors. 

"When companies like Walmart and CVS, known for delivering products at a cost-effective price, look at healthcare, jump in and then jump out saying it's unsustainable, it raises concerns," Nari Heshmati, MD, chief physician executive of Fort Myers, Fla.-based Lee Health's Physician Group , told Becker's. "If Walmart can't do it with embedded clinics in their stores, how can the average physician practice survive?"

This will only get more difficult as the behemoths in healthcare exert greater pressure on physician pay, as evidenced by continued reimbursement reductions by CMS. On July 10, CMS proposed a 2.8% conversion factor reduction to its physician fee schedule. According to research from the American Medical Association, Medicare physician payment declined 29% from 2001 to 2024 without accounting for the most recent proposed cut. 

The bottom line is getting bigger is not the ultimate answer except for capturing a greater area for acceptance by huge payors such as Humana, United Health Group, Aetna, and others.

"The proposed CMS pay cut for physicians can have significant implications across the healthcare system," Ernest Braxton, MD, spine and neurological surgery specialist at Vail-Summit Orthopaedics and Neurosurgery, told Becker's. "CMS efforts to control costs will have unintended consequences on physician workforce morale, patient care quality, and healthcare access. This will be the last straw for many private practice physicians. We will see more early retirements and a large number of physicians opting out of Medicare in order to create private pay contracts with patients for non-urgent/emergency care — shifting the economic burden to healthcare consumers."

Many feel the pressure to remain financially feasible weighs on healthcare success. 







'If Walmart can't do it … how can the average physician survive?': Independent practices becoming less feasible

Thursday, August 1, 2024

Med schools are full. Why are we running out of doctors? | Dr. Rafael J....


It will get worse. How can we correct this challenge?

Transcript